×
About 335 results

ALLMedicine™ Microcystic Adnexal Carcinoma Center

Research & Reviews  161 results

Microcystic adnexal carcinoma of the head and neck: Characteristics, treatment, and sur...
https://doi.org/10.1111/dth.14559
Dermatologic Therapy; Behbahani S, Yeh CJ et. al.

Nov 19th, 2020 - Studies on microcystic adnexal carcinoma (MAC) survival rates have been limited. This effort examines the association of patient demographics, treatment modalities, and tumor stage with overall survival (OS) in patients with MAC of the head and ne...

Sequencing of Sclerosing Microcystic Adenocarcinoma Identifies Mutational Burden and So...
https://doi.org/10.21873/anticanres.14658
Anticancer Research; Jiang R, Marquez J et. al.

Oct 28th, 2020 - Sclerosing microcystic adenocarcinoma (SMA) is a rare oral cavity neoplasia, histologically resembling microcystic adnexal carcinoma (MAC) of the skin. Only nine SMA cases have been reported in the literature, frequently in the context of immunosu...

Microcystic adnexal carcinoma with germinative follicular differentiation.
https://doi.org/10.1111/cup.13869
Journal of Cutaneous Pathology REFERENCES; Moya-Martínez C, Torre-Castro J et. al.

Sep 8th, 2020 - Microcystic adnexal carcinoma (MAC) is a low-grade adnexal carcinoma with controversial lines of differentiation. We present here an example of MAC showing histopathologic findings of germinative follicular differentiation in the form of solid agg...

Multifocal Recurrent Microcystic Adnexal Carcinoma.
https://doi.org/10.1097/SCS.0000000000006502
The Journal of Craniofacial Surgery; Teixeira JC, Patel V et. al.

May 13th, 2020 - Microcystic adnexal carcinoma (MAC) is a rare and locally aggressive neoplasm with preponderance for local recurrence but rarely nodal or distant metastasis. A 38-year-old male was referred to our clinic for definitive treatment of known recurrent...

Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in...
https://doi.org/10.1038/s41379-019-0424-4 10.1016/j.jaad.2018.03.010 10.1046/j.1524-4725.2000.00005.x 10.1159/000074122 10.1097/COC.0b013e318197924c 10.21873/anticanres.11377 10.1288/00005537-199511000-00011 10.1111/jdv.13127 10.3109/09546634.2015.1089351 10.1111/j.1610-0387.2009.07254_supp.x 10.1002/1097-0142(19820801)50:3<566::AID-CNCR2820500330>3.0.CO;2-Q 10.1097/00000372-199510000-00006 10.1159/000057880 10.1097/DAD.0b013e3181ea1385 10.1097/DAD.0b013e31825988df 10.1111/cup.12085 10.1038/modpathol.3801000 10.1016/S0165-4608(96)00417-7 10.1097/DAD.0b013e3181984f10 10.1371/journal.pone.0047290 10.1034/j.1600-0560.2000.027001030.x 10.1016/j.humpath.2015.12.015 10.1016/j.pathol.2017.10.011 10.1016/j.anndiagpath.2015.08.002 10.1002/(SICI)1097-0215(19980504)76:3<317::AID-IJC5>3.0.CO;2-Y 10.1038/modpathol.2011.48 10.1016/j.neo.2015.03.004 10.1158/1541-7786.MCR-14-0578 10.1007/s00428-014-1699-y 10.1038/modpathol.2016.79 10.1016/j.jmoldx.2014.09.008 10.1073/pnas.90.9.4216 10.1002/mc.2940090208 10.1002/(SICI)1096-8652(199712)56:4<206::AID-AJH2>3.0.CO;2-0 10.1038/modpathol.3880400 10.1126/science.1164368 10.1038/nature11017 10.1158/0008-5472.CAN-15-0702 10.1016/j.cell.2015.03.053 10.18632/oncotarget.8431 10.1038/nm.4333 10.1038/nature10725 10.1111/php.12377 10.1038/modpathol.2015.154 10.1001/jamadermatol.2017.0507 10.1007/978-0-387-77574-6_13 10.1038/jid.2013.276 10.1002/hed.25613 10.1158/1078-0432.CCR-14-1768 10.1038/ng.3525 10.2174/138161211795222603 10.1038/sj.onc.1201459 10.3389/fonc.2015.00284 10.1097/00000372-199404000-00003 10.1016/S0140-6736(05)71142-9 10.1038/nature03546 10.1056/NEJMoa051113 10.1016/j.ccr.2005.03.023 10.1084/jem.20072182 10.1038/onc.2012.347 10.1016/S0092-8674(00)81277-5 10.1038/nm0996-968 10.1016/S0161-5890(00)00018-3 10.12688/f1000research.13167.1 10.18632/oncotarget.4494 10.1126/scitranslmed.aad3001 10.1038/nature13480 10.1111/his.13339 10.1038/s41379-019-0269-x 10.1016/j.humpath.2018.08.032 10.1002/gcc.22345 10.1093/jnci/djv256 10.1016/S1470-2045(17)30603-4 10.18632/oncotarget.13129 10.1111/j.1349-7006.2006.00386.x 10.1016/j.ccr.2007.02.007 10.1038/modpathol.2015.96 10.1371/journal.pone.0141867 10.1007/s00428-016-1954-5 10.1007/s00432-017-2528-x 10.1097/PAS.0000000000000734 10.1097/PAS.0000000000001261 10.1016/j.anndiagpath.2016.04.006 10.1016/j.humpath.2017.10.004
Modern Pathology : an Official Journal of the United Stat... Chan MP, Plouffe KR et. al.

Dec 20th, 2019 - Microcystic adnexal carcinoma is a locally aggressive sweat gland carcinoma characterized by its infiltrative growth and histopathologic overlap with benign adnexal tumors, often posing challenges to both diagnosis and management. Understanding th...

see more →

Clinicaltrials.gov  161 results

Microcystic adnexal carcinoma of the head and neck: Characteristics, treatment, and sur...
https://doi.org/10.1111/dth.14559
Dermatologic Therapy; Behbahani S, Yeh CJ et. al.

Nov 19th, 2020 - Studies on microcystic adnexal carcinoma (MAC) survival rates have been limited. This effort examines the association of patient demographics, treatment modalities, and tumor stage with overall survival (OS) in patients with MAC of the head and ne...

Sequencing of Sclerosing Microcystic Adenocarcinoma Identifies Mutational Burden and So...
https://doi.org/10.21873/anticanres.14658
Anticancer Research; Jiang R, Marquez J et. al.

Oct 28th, 2020 - Sclerosing microcystic adenocarcinoma (SMA) is a rare oral cavity neoplasia, histologically resembling microcystic adnexal carcinoma (MAC) of the skin. Only nine SMA cases have been reported in the literature, frequently in the context of immunosu...

Microcystic adnexal carcinoma with germinative follicular differentiation.
https://doi.org/10.1111/cup.13869
Journal of Cutaneous Pathology REFERENCES; Moya-Martínez C, Torre-Castro J et. al.

Sep 8th, 2020 - Microcystic adnexal carcinoma (MAC) is a low-grade adnexal carcinoma with controversial lines of differentiation. We present here an example of MAC showing histopathologic findings of germinative follicular differentiation in the form of solid agg...

Multifocal Recurrent Microcystic Adnexal Carcinoma.
https://doi.org/10.1097/SCS.0000000000006502
The Journal of Craniofacial Surgery; Teixeira JC, Patel V et. al.

May 13th, 2020 - Microcystic adnexal carcinoma (MAC) is a rare and locally aggressive neoplasm with preponderance for local recurrence but rarely nodal or distant metastasis. A 38-year-old male was referred to our clinic for definitive treatment of known recurrent...

Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in...
https://doi.org/10.1038/s41379-019-0424-4 10.1016/j.jaad.2018.03.010 10.1046/j.1524-4725.2000.00005.x 10.1159/000074122 10.1097/COC.0b013e318197924c 10.21873/anticanres.11377 10.1288/00005537-199511000-00011 10.1111/jdv.13127 10.3109/09546634.2015.1089351 10.1111/j.1610-0387.2009.07254_supp.x 10.1002/1097-0142(19820801)50:3<566::AID-CNCR2820500330>3.0.CO;2-Q 10.1097/00000372-199510000-00006 10.1159/000057880 10.1097/DAD.0b013e3181ea1385 10.1097/DAD.0b013e31825988df 10.1111/cup.12085 10.1038/modpathol.3801000 10.1016/S0165-4608(96)00417-7 10.1097/DAD.0b013e3181984f10 10.1371/journal.pone.0047290 10.1034/j.1600-0560.2000.027001030.x 10.1016/j.humpath.2015.12.015 10.1016/j.pathol.2017.10.011 10.1016/j.anndiagpath.2015.08.002 10.1002/(SICI)1097-0215(19980504)76:3<317::AID-IJC5>3.0.CO;2-Y 10.1038/modpathol.2011.48 10.1016/j.neo.2015.03.004 10.1158/1541-7786.MCR-14-0578 10.1007/s00428-014-1699-y 10.1038/modpathol.2016.79 10.1016/j.jmoldx.2014.09.008 10.1073/pnas.90.9.4216 10.1002/mc.2940090208 10.1002/(SICI)1096-8652(199712)56:4<206::AID-AJH2>3.0.CO;2-0 10.1038/modpathol.3880400 10.1126/science.1164368 10.1038/nature11017 10.1158/0008-5472.CAN-15-0702 10.1016/j.cell.2015.03.053 10.18632/oncotarget.8431 10.1038/nm.4333 10.1038/nature10725 10.1111/php.12377 10.1038/modpathol.2015.154 10.1001/jamadermatol.2017.0507 10.1007/978-0-387-77574-6_13 10.1038/jid.2013.276 10.1002/hed.25613 10.1158/1078-0432.CCR-14-1768 10.1038/ng.3525 10.2174/138161211795222603 10.1038/sj.onc.1201459 10.3389/fonc.2015.00284 10.1097/00000372-199404000-00003 10.1016/S0140-6736(05)71142-9 10.1038/nature03546 10.1056/NEJMoa051113 10.1016/j.ccr.2005.03.023 10.1084/jem.20072182 10.1038/onc.2012.347 10.1016/S0092-8674(00)81277-5 10.1038/nm0996-968 10.1016/S0161-5890(00)00018-3 10.12688/f1000research.13167.1 10.18632/oncotarget.4494 10.1126/scitranslmed.aad3001 10.1038/nature13480 10.1111/his.13339 10.1038/s41379-019-0269-x 10.1016/j.humpath.2018.08.032 10.1002/gcc.22345 10.1093/jnci/djv256 10.1016/S1470-2045(17)30603-4 10.18632/oncotarget.13129 10.1111/j.1349-7006.2006.00386.x 10.1016/j.ccr.2007.02.007 10.1038/modpathol.2015.96 10.1371/journal.pone.0141867 10.1007/s00428-016-1954-5 10.1007/s00432-017-2528-x 10.1097/PAS.0000000000000734 10.1097/PAS.0000000000001261 10.1016/j.anndiagpath.2016.04.006 10.1016/j.humpath.2017.10.004
Modern Pathology : an Official Journal of the United Stat... Chan MP, Plouffe KR et. al.

Dec 20th, 2019 - Microcystic adnexal carcinoma is a locally aggressive sweat gland carcinoma characterized by its infiltrative growth and histopathologic overlap with benign adnexal tumors, often posing challenges to both diagnosis and management. Understanding th...

see more →

News  13 results

Mohs Micrographic Surgery for Digital Melanoma and Nonmelanoma Skin Cancers
https://www.mdedge.com/dermatology/article/164863/melanoma/mohs-micrographic-surgery-digital-melanoma-and-nonmelanoma-skin/page/0/1

May 3rd, 2018 - Comment Mohs micrographic surgery is a specialized technique used in the treatment of cutaneous tumors, including basal cell carcinoma, SCC, melanoma in situ, atypical fibroxanthoma, dermatofibrosarcoma protuberans, sebaceous carcinoma, microcysti.

Resolution of refractory pruritus with aprepitant in a patient with microcystic adnexal carcinoma
https://www.mdedge.com/hematology-oncology/article/164492/patient-survivor-care/resolution-refractory-pruritus-aprepitant
Song et al

Apr 29th, 2018 - Substance P is an important neurotransmitter implicated in itch pathways. 1 After binding to its receptor, neurokinin-1 (NK-1), substance P induces release of factors including histamine, which may cause pruritus.

Indurated Plaque on the Eyebrow
https://www.mdedge.com/dermatology/article/153238/dermatopathology/indurated-plaque-eyebrow
Ryan Bogner, MD, Tye Haeberle, MD et. al.

Dec 1st, 2017 - The Diagnosis: Microcystic Adnexal Carcinoma Microcystic adnexal carcinoma (MAC) is a rare, low-grade adnexal carcinoma consisting of both ductal and pilar differentiation. 1 It typically presents in young to middle-aged adults as a flesh-colored o.

Flesh-Colored Nodule With Underlying Sclerotic Plaque
https://www.mdedge.com/dermatology/article/135537/nonmelanoma-skin-cancer/flesh-colored-nodule-underlying-sclerotic-plaque
Amira Elbendary, MBBCh, MSc, Manuel Valdebran, MD et. al.

Apr 11th, 2017 - The Diagnosis: Collision Tumor Excisional biopsy and histopathological examination demonstrated a collision tumor composed of a benign intradermal melanocytic nevus, tumor of follicular infundibulum, and an underlying sclerosing epithelial neoplas.

see more →